<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Veterinary Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3"><gtr:id>1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Bryant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH021930%2F1"><gtr:id>60C66B58-EE23-4095-8D0F-FED41B14E0A8</gtr:id><gtr:title>A mathematical and biophysical analysis of salmonella macrophage interactions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/H021930/1</gtr:grantReference><gtr:abstractText>Salmonella enterica causes a wide range of diseases in many animals. Economic losses to the farming industry through Salmonella infection are potentially very high, but also important is the fact that a number of serovars that infect animals can also cause food poisoning and gastroenteritis in humans. Salmonella infect specialised immune cells (macrophages) where the bacteria reside within an intracellular compartment called the salmonella-containing vacuole. Within the macrophage the bacteria may be killed, may hide, may grow and can cause the cell to die. The interaction between macrophages and salmonellae is critically important to the progression of disease. Controlling the numbers of bacteria within the macrophage is an important step in enabling the host to stop the bacteria growing and to survive infection. Many mechanisms involved in the interaction between Salmonella and macrophages are unclear. In particular little is known about how the macrophage physically interacts with the cell. The macrophage detects the presence of bacteria through specialised proteins called Pattern Recognition Receptors (PRRs) which induce macrophage responses to help the host control a salmonella infection. In this project I will use mathematical models to predict how PRR activity effects the process by which Salmonella infect macrophages and then test these theoretical assumptions using biological experiments. I will use physical techniques to investigate whether PRRs influence how Salmonella associate with macrophages. In the final part of the project I will compare how PRR activity affects the global response of macrophages to infection. This project will increase our understanding of how Salmonella infect macrophages and may deliver new targets for developing drugs to treat the diseases caused by these pathogens.</gtr:abstractText><gtr:technicalSummary>A crucial aspect of the pathogenesis of invasive Salmonella infections is the ability of the pathogen to invade and survive within phagocytes. Pattern Recognition Receptors (PRRs) on macrophages allow the host to detect pathogens. Many different PRRs detect Salmonella serovars yet the physiological role for most of these proteins in the host response to infection is unclear. Different Salmonella serovars produce bacterial proteins that modulate PRR signaling. The macrophage response to infection involves PRR signaling in concert with the activity of salmonellae factors, but the precise balance of how this occurs is unknown. The question I am therefore asking in this research proposal is what is the contribution of PRRs and bacterial factors to the macrophage control of salmonellosis? This project will use biological, physical and mathematical techniques to study the fundamental mechanisms by which Salmonella enterica serovar Typhimurium (STm) infects macrophages and to determine whether PRRs influence these processes. Iterations of experimental analysis and mathematical models will be used to determine how PRRs affect the process of macrophage infection by STm. Biophysical analysis will be used to determine whether PRRs affect the physical interaction between STm and the macrophage. The final part of this project will be to compare the signaling networks activated by bacterial ligands (such as STm lipopolysaccharide and flagellin) with live STm in macrophages to identify the importance of bacterial factors involved in the cellular infection process.</gtr:technicalSummary><gtr:potentialImpactText>The major beneficiaries of this research will be academics in the biological, physical and mathematical sciences. The work will be of particular interest to immunologists and microbiologists. The research will be published in international open access journals to ensure wide access to the data generated by this work. In the long term novel technologies may arise from the physical analysis of Salmonella-macrophage interactions and this will be of benefit to scientists wishing to apply our technologies to other research questions. Should novel technologies arise then they will be developed by Cambridge Enterprise, the University of Cambridge office responsible for commercializing our scientific work. The generation of a macrophage signaling network in response to Salmonella infection may identify novel targets for drug development to prevent salmonellosis which will be on interest to the pharmaceutical industry. Any intellectual property arising from this work will again be developed by Cambridge Enterprise. Our work will generate a number of movies which may be useful teaching material particularly to children explaining how bacteria interact with cells. This material will be used in presentations of the research at the Cambridge Science fair and through the BBSRC media office. I will attend the BBSRC media course in order to develop my communication skills and I plan to run a website where the movies will be available to download.</gtr:potentialImpactText><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>255018</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mike White</gtr:description><gtr:id>0791A5D0-D052-4D5A-89B9-9D469AB50607</gtr:id><gtr:impact>Development of new freeware computer software to track single cell movement and translocation of nuclear factor kappa B</gtr:impact><gtr:outcomeId>5457a60ce33db1.15543669-1</gtr:outcomeId><gtr:partnerContribution>Technology transfer and collaborative discussions</gtr:partnerContribution><gtr:piContribution>Technology transfer and collaborative discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International and national collaboration with David Underhill</gtr:description><gtr:id>697BC021-35B9-4523-85B8-6FA398A57D42</gtr:id><gtr:outcomeId>b95f317eb95f3192-1</gtr:outcomeId><gtr:piContribution>Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2000-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>Doug Golenbock, University of Massachusetts Medical School</gtr:description><gtr:id>9869417B-8D2D-427C-BBFE-72441855042F</gtr:id><gtr:outcomeId>b95f35e8b95f35fc-1</gtr:outcomeId><gtr:piContribution>I went on sabbatical to the Golenock laboratory for 2 months in 2008</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaboration with Eicke Laetz</gtr:description><gtr:id>2551E80D-2BC3-47E8-978F-37DDF2D19DF3</gtr:id><gtr:outcomeId>b95f36e2b95f36f6-1</gtr:outcomeId><gtr:piContribution>University of Massachusetts Medical School</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Respiratory Biology GSK</gtr:department><gtr:description>Collaboration with GSK</gtr:description><gtr:id>9DE16508-B36C-4327-8073-8B347EBB4CEA</gtr:id><gtr:impact>New collaboration</gtr:impact><gtr:outcomeId>56b2842f91e2e5.13491863-1</gtr:outcomeId><gtr:partnerContribution>Provision of expertise, novel knock out mice, CRISPR screens in human cells, epithelia from patients</gtr:partnerContribution><gtr:piContribution>We hold a GSK-Varsity grant to understand why bacteria stick to epithelial cells from patients. We are developing assays for increasing the scale of screening for bacterial adherance to cells, generating bacterial mutants to prevent bacterial adhesion and looking at novel human molecules that may be important for bacterial adherance</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetech, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Genentech Visiting Professorship</gtr:description><gtr:id>BF57BCB6-C68F-4392-9D05-DEFB8C8D6AB8</gtr:id><gtr:impact>None yet as the work is still in progress</gtr:impact><gtr:outcomeId>58bea1c5e94e86.75233010-1</gtr:outcomeId><gtr:partnerContribution>My collaborators gave me novel reagents and supported my research during my time in the USA</gtr:partnerContribution><gtr:piContribution>I visited Genentech South San Francisco site and performed research in the laboratory there for 9 months. Two of my PhD students also had 3 month internships working with myself and my Genentech collaborators. We learnt new techniques and gained access to new reagents. I intellectually contributed to their inflammasome research program.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK Immunology Catalyst Sabbatical Award</gtr:description><gtr:id>9AC210A5-7BFF-421E-85F7-2C4D53540CE8</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bea4f2263ab3.75559105-1</gtr:outcomeId><gtr:partnerContribution>GSK bought out my teaching and administration duties for 3 years and fund 2 postdoctoral researchers to work with me at GSK</gtr:partnerContribution><gtr:piContribution>GSK have bought out my teaching and administration duties for 3 years. I spend 3 days a week at GSK and have 2 postdoctoral researchers at GSK. I am working on inflammasome biology and Pattern Recognition Receptor research. I intellectually input into several of the GSK therapeutic units.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>International and national collaboration with Shizuo Akira, Osaka University</gtr:description><gtr:id>D532F9B4-9680-4AFE-95F9-326BBDBEDD9F</gtr:id><gtr:outcomeId>b95f307ab95f308e-1</gtr:outcomeId><gtr:piContribution>Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>1999-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaborations with Kate Fitzgerald</gtr:description><gtr:id>58A4382D-FD34-4500-8FCF-81BCDAEC76D8</gtr:id><gtr:impact>Publications linked to our research grants have been facilitated by this collaboration.</gtr:impact><gtr:outcomeId>b95f3bceb95f3be2-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents, cell lines and intellectual input to our research.</gtr:partnerContribution><gtr:piContribution>Intellectual input and collaborative discussions about common research interests.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lafferty Debate participant</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D074DF2B-2314-4895-8DF7-4B011639947D</gtr:id><gtr:impact>Participated in a public debate on &amp;quot;Adaptive Immunity is innately redundant&amp;quot;</gtr:impact><gtr:outcomeId>58bebfd38e8595.88528426</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>There are 100 trillion Bacteria in Your Gut: How do we protect ourselves against infection?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>05451275-CF45-4F12-976E-72AA5C3D4FFE</gtr:id><gtr:impact>Public Talk Queens' College, Cambridge

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-8473004548.3196190c25fa22</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bacterial recognition by PRRs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>96F2A555-129B-4DEA-8E68-25F040EC553C</gtr:id><gtr:impact>Toll2011, Garda, Italy: &amp;quot;Bacterial recognition by PRRs&amp;quot;

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5943624308.2802960ce3ccdc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute for Child Heath, London (2011):Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BF67E3A7-BA13-4720-A2D9-0798B3F5DF6C</gtr:id><gtr:impact>Institute for Child Heath, London

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-977243493.28991350cdc23b0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: therapeutic targets for allergic as well as infectious diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>local</gtr:geographicReach><gtr:id>1E623880-30CB-4294-864F-CAC2BA74AA08</gtr:id><gtr:impact>Invited talk at Cambridge Institute for Medical Research, Cambridge.

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5832447554.7600980be9ade2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70ED9054-8F13-4285-A055-174214631D93</gtr:id><gtr:impact>Talk to University of Massachusetts Medical School, Worcester, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-651868209.84992040bec7f40</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What can maths and physics do for infection biology?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7F41BA57-FFDC-4619-A0F9-F69CE06232C1</gtr:id><gtr:impact>Invited talk at Cardiff University School of Biosciences

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-9003328652.1242260c2a1e54</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE68F765-293C-41B1-A19F-31FC3F259ECB</gtr:id><gtr:impact>NIH NIAID, Bethesda, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4477234123.7191430beb5e26</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>719B2E20-1C31-4026-9CC7-301AEF69596A</gtr:id><gtr:impact>Talk to the University of Maryland, Baltimore, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-7628979950.7977250be8e646</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>917208</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Effects of Nod-like receptor activity on protective immunity against Salmonella infection</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K006436/1</gtr:fundingRef><gtr:id>EF1036AD-05B4-4569-97CF-8C889D4C1F71</gtr:id><gtr:outcomeId>5ee5841a5ee5842e</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Varsity Award</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>5A6C7EF7-BEB9-40FA-B7F8-A359CC1123BA</gtr:id><gtr:outcomeId>56c3ae79ea77d5.53891767</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>267000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Wolfson Refurbishment Scheme</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>84473486-E27C-49D9-BC4E-732C174B23BE</gtr:id><gtr:outcomeId>56b289997518d2.05135438</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Elion and Black Immunology Catalyst Sabbatical Award</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>89A15D19-5EA7-4D44-87BC-685B78CB24CE</gtr:id><gtr:outcomeId>56c3aee548a740.84843292</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Interdisciplinary Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-IRG2014-13</gtr:fundingRef><gtr:id>6352A0A2-6434-4395-A93C-BDC749728FE6</gtr:id><gtr:outcomeId>545798555e4953.51071796</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Wellcome Trust Investigator Award</gtr:description><gtr:end>2021-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>559B77A5-A6A6-4944-8E26-9832BB61FAB8</gtr:id><gtr:outcomeId>56b28923cd5dd9.84179062</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The impact from this work includes several outputs
1. Scientific communications including the publication of several papers and the presentation of several talks to fellow academics
2. Public Communication of Science: I gave the following talk to 3 college open days for children and the general public (Queens', Peterhouse, Downing) and to the Society for Biology in Cambridge. &amp;quot;There are 100 trillion bacteria in your gut: how do we protect ourselves against infection?&amp;quot; I also featured in a 2010 BBC Radio Cambridgeshire &amp;quot;The Naked Scientists&amp;quot; program presenting a talk on our collaborative work with physicists entitled &amp;quot;How do lasers pick up bacteria?&amp;quot;.
3. Development of multi-disciplinary research collaborations leading to further funding as well as application of new techniques to immunological and vaccinology research</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>1530A53C-5DD3-4A8F-820B-36827DA73761</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5457a3816a31c1.92776871</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The aim of this fellowship project was to use mathematical and biophysical analytical methods to study how the food borne pathogen Salmonella enterica serovar Typhimurium infects macrophages. This is important because after infecting the host in vivo S. Typhimurium hides and grows within macrophages to evade the immune system then kills the cells to spread infection. In particular the project centred around understanding whether the host Pattern Recognition Receptors (PRRs), NOD-Like Receptor C4 (NLRC4) and Toll-like receptor 4 (TLR4), were involved in the physical process of infection. 
 The work on the fellowship project made several important observations. Using iterations of mathematical models and experiments we found that, despite S. Typhimurium being a parasite of macrophages, very few of these cells became infected by the bacterium. This is a surprise because macrophages readily phagocytose (engulf) particles so would be expected to take up bacteria and S. Typhimurium also produces invasion proteins to promote active invasion of cells. Using live imaging techniques it became clear that the majority of bacteria failed to invade macrophages. Once infected a macrophage could undergo secondary infection events, but this happened relatively rarely. This is because once a macrophage is invaded by the Salmonella proteins produced by the bacterium activates cytosolic NLRC4 which alters the cellular cytoskeletal proteins making the cell stiffer to reduce further uptake of bacteria. This is particularly interesting because it is the bacterial invasion proteins that activate NLRC4 to drive cellular stiffening, but it now appears these proteins also limit the number of infection events that can occur per cell and hence maximising the resources available for the resident bacterium to grow. 
 Once infected by Salmonella another consequence of this infection-induced stiffness is to arrest cellular movement. This is important because in vivo infected macrophages are the central cells for controlling bacterial growth by forming abscesses which wall off the cells infected by bacteria to prevent further bacterial spread. Stasis of infected macrophages is likely to be a critical early step in driving abscess formation. Mice lacking NLRC4 have dispersed and poorly formed abscesses which supports this hypothesis. 
 In other work funded by the BBSRC we had observed that infection of macrophages by Salmonella activates two cytosolic NLRs, NLRC4 and also NLRP3. When an NLR is activated it recruits a protein, ASC, to form a massive cytosolic protein complex called the ASC speck. We noted that despite two NLRs being activated only one ASC protein complex forms per cell. Using super-resolution microscopy we have shown that the ASC speck contains both NLRC4 and NLRP3 at the same time contradicting the currently accepted dogma that each NLR will form its own ASC speck. 
 TLR4 has little effect on the physical process of infection. TLR4 is critical for driving the cellular signalling process that leads to the formation of host protective cytokines and this process differs when driven by live bacteria rather than compounds that activate this receptor.</gtr:description><gtr:exploitationPathways>Our findings may be used in development of new approaches to immunology research for use in vaccine discovery programs and in education</gtr:exploitationPathways><gtr:id>3C97BA06-D8BF-4222-BF93-2EDCF0F92C3A</gtr:id><gtr:outcomeId>5457a1dad60f76.70904483</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Education,Healthcare</gtr:sector></gtr:sectors><gtr:url>http://www.vet.cam.ac.uk/directory/ceb27@cam.ac.uk</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E3DBA2EB-237E-46EB-9E3D-006591463E4D</gtr:id><gtr:title>The frequency and duration of Salmonella-macrophage adhesion events determines infection efficiency.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89ccc0f8d470f7b083907c99fa22118d"><gtr:id>89ccc0f8d470f7b083907c99fa22118d</gtr:id><gtr:otherNames>Achouri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>doi_55f94d94d299f0f8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCFF02E0-9406-425F-A88F-FACEB87CE6BC</gtr:id><gtr:title>Bacterial infection of macrophages induces decrease in refractive index.</gtr:title><gtr:parentPublicationTitle>Journal of biophotonics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15c0477f7fe725031173f29c6a847837"><gtr:id>15c0477f7fe725031173f29c6a847837</gtr:id><gtr:otherNames>Ekpenyong AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1864-063X</gtr:issn><gtr:outcomeId>544531ab6edf05.67368031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF50CC9F-7A52-4DA5-B5E4-3037144B701B</gtr:id><gtr:title>Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96679259ad3b8888bb7ca701e5756efe"><gtr:id>96679259ad3b8888bb7ca701e5756efe</gtr:id><gtr:otherNames>Latty S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a90460d38a286.69286409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F507A29E-B426-461E-8BDD-7F09A6F25516</gtr:id><gtr:title>The relationship between glial cell mechanosensitivity and foreign body reactions in the central nervous system.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c65e6fb20ecf4ff1de668ede2bb9d0f"><gtr:id>4c65e6fb20ecf4ff1de668ede2bb9d0f</gtr:id><gtr:otherNames>Moshayedi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>5456b0f8433de6.35801500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C65BD70-65DE-4068-8436-8778A6CB6963</gtr:id><gtr:title>Assessing the Collective Dynamics of Motile Cilia in Cultures of Human Airway Cells by Multiscale DDM.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/743001186eee7ac7e7f997ec36bccaa4"><gtr:id>743001186eee7ac7e7f997ec36bccaa4</gtr:id><gtr:otherNames>Feriani L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>5a60db13896e99.75589171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B591D60-2594-4600-B9B3-A3018E4AB92E</gtr:id><gtr:title>Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16da9594eedf0f15c85fe9f971d8e9c9"><gtr:id>16da9594eedf0f15c85fe9f971d8e9c9</gtr:id><gtr:otherNames>Jafari NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5456bf4070f6a8.97623305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85C8E066-4EF8-40DD-B824-DE3B1CBB4EBA</gtr:id><gtr:title>Abnormal Nasal Nitric Oxide Production, Ciliary Beat Frequency, and Toll-like Receptor Response in Pulmonary Nontuberculous Mycobacterial Disease Epithelium</gtr:title><gtr:parentPublicationTitle>American Journal of Respiratory and Critical Care Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09a84e3efe4f960b41c5b1345892d878"><gtr:id>09a84e3efe4f960b41c5b1345892d878</gtr:id><gtr:otherNames>Fowler, C.J.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>5456bb22be5e01.43176526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>234410A2-45AD-4454-BDF0-2BD6DE73613A</gtr:id><gtr:title>Lipopolysaccharide-induced NF-?B nuclear translocation is primarily dependent on MyD88, but TNFa expression requires TRIF and MyD88.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/982db68136bc0805ca8cca9fac8a1822"><gtr:id>982db68136bc0805ca8cca9fac8a1822</gtr:id><gtr:otherNames>Sakai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9043526b30b2.50615221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>694902DF-7207-4539-B039-C2176F3E40CB</gtr:id><gtr:title>Phagocytosis dynamics depends on target shape.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b9c5e3b61ae4bb3e1cfd4a9df48981a"><gtr:id>7b9c5e3b61ae4bb3e1cfd4a9df48981a</gtr:id><gtr:otherNames>Paul D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>5456dd1d23ae22.60255486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8990ADD6-F3E2-45CB-93C7-248D4D408350</gtr:id><gtr:title>A quantitative comparison of single-dye tracking analysis tools using Monte Carlo simulations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c648d38d66f50de331bc27c1d93ec9"><gtr:id>31c648d38d66f50de331bc27c1d93ec9</gtr:id><gtr:otherNames>Weimann L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5456bc526ff2f1.98693577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B56EDC-94A0-4FE2-81C5-789104C7CB49</gtr:id><gtr:title>Dynamics of Salmonella infection of macrophages at the single cell level.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f387dc3e7f93d87fd55b6a14687d547"><gtr:id>5f387dc3e7f93d87fd55b6a14687d547</gtr:id><gtr:otherNames>Gog JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>544531aba1a027.88441078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D977F64B-C976-4221-844A-F24ACF41C0CA</gtr:id><gtr:title>Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1? production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544531ab31eec1.34420211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1FCFE5C-2005-4E42-872D-C3DA0A130473</gtr:id><gtr:title>Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55f94b94bf831951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3753162-D4A5-4A8A-8752-127B37461201</gtr:id><gtr:title>Actin polymerization as a key innate immune effector mechanism to control Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5675dd0d71fab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2094D3C-6723-4456-B39B-8ABCFCC64A4C</gtr:id><gtr:title>Activation of innate immunity by lysozyme fibrils is critically dependent on cross-? sheet structure.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b0013d1e73ab76b2d112992473ceb00"><gtr:id>9b0013d1e73ab76b2d112992473ceb00</gtr:id><gtr:otherNames>Gustot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>5456dedcae4b16.59915941</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H021930/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>